App aims to help doctors monitor young patients’ hearts Doctors at Children’s Mercy Hospital are keeping tabs on their some of their sickest patients with the help of an app they developed to monitor their hearts.
Doctors should ask heart patients about secondhand smoke, study says Not all heart disease patients know that secondhand smoke is bad for them – and not all doctors are asking them if they live with a smoker, according to a new study.
Here's why you might want to stop drinking out of cans Might want to make your next six-pack glass bottles.
FDA approves Sanofi/Regeneron cholesterol drug with limits The U.S. Food and Drug Administration approved a potent new cholesterol-lowering drug from Sanofi SA and Regeneron Pharmaceuticals Inc on Friday but limited its approved use to patients with a hereditary form of the condition and those with cardiovascular disease.
FDA weighs approval of first-in-class cholesterol drug Federal health regulators said Friday that a highly-anticipated, experimental drug from Sanofi lowers bad cholesterol more than older drugs. But officials have questions about whether to approve the drug based on that measure alone or whether to wait for additional study results.
Higher levels of statins linked to diabetes People with heart problems who were started on cholesterol-lowering statins were more likely to develop diabetes if they were prescribed stronger versions of the drugs, a new study finds.
Insulin pump may cut risk of heart disease deaths with diabetes People with type 1 diabetes must control their blood sugar with insulin, but getting it automatically from an implanted pump may also help to stave off death from heart disease, according to a large Scandinavian study.
Cholesterol linked to Alzheimer's protein, unclear why Patterns of "good" and "bad" cholesterol usually associated with heart risks also predicted the levels of Alzheimer's-related beta amyloid protein seen in the brains of study participants.
Heart stents may require longer blood thinner use Millions of people with stents that prop open clogged heart arteries may need anti-clotting drugs much longer than the one year doctors recommend now.
